Bullfrog AI (BFRG) vs BioVie (BIVI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
BioVie (BIVI) has outperformed Bullfrog AI (BFRG) over the past year, losing 35.0% versus a loss of 55.6%. BioVie is the larger company by market cap ($12.0 million vs $11.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BFRG | BIVI |
|---|---|---|
| Share price | $0.6406 | $1.38 |
| Market cap | $11.88M | $11.98M |
| 1-day change | -7.48% | +7.82% |
| YTD return | -21.59% | +10.34% |
| 1-year return | -55.62% | -35.03% |
| 5-year return | — | -99.78% |
| EPS (TTM) | $-0.46 | $-3.05 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.96 | $3.79 |
| 52-week low | $0.425 | $0.82 |
| Distance from 52-week high | -67.32% | -63.59% |
| Analyst consensus | none | none |
| Avg. price target upside | — | +281.13% |
| Average volume | 5.34M | 4.60M |
| Shares outstanding | 18.54M | 8.68M |
| Employees | 9 | 13 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BIVI has outperformed BFRG by 20.6 percentage points over the past year.
About Bullfrog AI
BFRG stock →Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 9 employees
About BioVie
BIVI stock →BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 3 for the treatment of life-threatening complications of liver cirrhosis and ascites due to hepatitis, nonalcoholic steatohepatitis, and alcoholism.
Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees
BFRG vs BIVI FAQ
Which is bigger, Bullfrog AI or BioVie?
BioVie (BIVI) is larger, with a market capitalization of $11.98M compared with $11.88M for Bullfrog AI (BFRG).
Which stock has performed better over the past year, BFRG or BIVI?
BIVI returned -35.03% over the past 12 months, compared with -55.62% for BFRG (price return, excluding dividends). Past performance does not predict future results.
Are Bullfrog AI and BioVie in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.